Teach on Udemy

Turn what you know into an opportunity and reach millions around the world.

Learn More

Your cart is empty.

Keep shopping

Clinical Trials: A Complete Guide for Professionals

Name: Clinical Trials: A Complete Guide for Professionals
Rating: 3.0 (1 reviews)

From Protocol to Regulatory Submission — Everything You Need to Know

New

Created byBashir Ahmed

Last updated 5/2026

English

What you'll learn

Explain what clinical trials are, why they exist, and how they fit into the drug development lifecycle
Describe the four phases of clinical trials and what each phase is designed to achieve
Identify every key stakeholder in a clinical trial — Sponsor, CRO, Investigator, IRB, Regulator — and their responsibilities
Understand the regulatory frameworks governing trials globally, including ICH GCP, FDA regulations, and EMA guidelines
Walk through the end-to-end operational lifecycle of a trial: start-up, conduct, monitoring, and closeout
Recognize the key technology systems used — CTMS, EDC, IWRS, eTMF — and how data flows between them
Explain how clinical data is managed from first data entry through database lock and statistical analysis
Describe the safety monitoring infrastructure, including adverse event reporting, the DSMB, and pharmacovigilance obligations
Understand how regulatory submissions are structured and submitted globally (NDA, BLA, MAA, eCTD)

Course content

11 sections • 44 lectures • 5h 9m total length

What Is a Clinical Trial?4:16
Definition and purpose of a clinical trial. The difference between observational studies and interventional studies. Real-world examples from blockbuster drugs.
Why Are Clinical Trials Necessary?5:02
The tragic history behind clinical regulation — thalidomide, Tuskegee, and how catastrophes shaped modern research ethics and law. Why trials protect patients and society.
The Drug Development Lifecycle5:54
End-to-end overview: Discovery → Pre-clinical → Clinical (Phase I-IV) → Regulatory Approval → Post-Marketing. Where clinical trials sit and how long each stage takes.
Knowledge Check - Clinical Trials

Phase I — First-in-Human Studies6:36
Primary goal: establish safety and tolerability. Dose escalation designs, small healthy volunteer populations (or patients in oncology), PK/PD measurements, and MTD determination.
Phase II — Proof of Concept5:33
Does it work? Efficacy signals, dose-finding, signal detection. Patient populations. Phase IIa vs IIb distinctions. The high rate of Phase II failure and why.
Phase III — Pivotal Trials4:46
Large-scale, randomized, controlled trials designed to demonstrate efficacy and safety for regulatory approval. Sample size, statistical power, endpoints, and blinding
Phase IV and Post-Marketing Studies9:20
Life after approval. Pharmacovigilance obligations, REMS programs, label expansions, comparative effectiveness, and real-world evidence generation.

What Is a Protocol and Why It Matters6:27
The protocol as the legal and scientific foundation of a trial. Regulatory requirement for a protocol under ICH E6. Who authors it and who must approve it.
Anatomy of a Protocol — Key Sections11:03
Walk-through of a typical protocol structure: objectives, design, population, eligibility criteria, treatment plan, assessments, endpoints, statistics, safety monitoring, and ethical considerations.
Protocol Amendments — When Plans Change8:16
Why protocols are amended, the difference between substantial and non-substantial amendments, regulatory notification requirements, and the operational impact on running trials.

The Sponsor — Owning the Trial5:26
Legal definition of a Sponsor under 21 CFR and ICH E6. Responsibilities that cannot be delegated. Sponsor-Investigator situations. The Sponsor's relationship with regulators.
Contract Research Organizations (CROs)3:19
Why Sponsors outsource and what can (and cannot) be transferred. Full-service vs. functional service providers. Oversight obligations that remain with the Sponsor under ICH E6 R2
The Principal Investigator and Site Staff3:44
The PI's legal and ethical accountability. The site team: Sub-Investigators, Study Coordinators, Pharmacists. Delegation of authority logs and site SOPs
Regulatory Authorities — FDA, EMA and Beyond4:11
The role of the FDA (CDER, CBER) and EMA in overseeing trials. MHRA, PMDA, and key global authorities. Inspections, GCP audits, and enforcement actions.
IRBs, Ethics Committees, and DSMBs7:51
The role of Institutional Review Boards (US) and Ethics Committees (EU) in protecting participants. Continuing review. The Data Safety Monitoring Board (DSMB) — independent safety oversight.

ICH E6 GCP — The Gold Standard6:45
ICH E6 R2 and the upcoming R3. Core GCP principles: rights and safety of subjects, data integrity, audit trail. Annexes for remote monitoring and risk-based approaches.
FDA Regulations — US Framework4:55
21 CFR Parts 11, 50, 54, 56, 312, and 314 explained in plain English. The Investigational New Drug (IND) application — types (Commercial, Research, Emergency), content, and timeline.
EMA, the Clinical Trial Regulation, and Global Landscape4:51
EU Clinical Trial Regulation (536/2014) and CTIS. The Clinical Trial Authorization (CTA) process. Japan (PMDA), Canada (CTA), and harmonization through the ICH framework.
The Trial Master File (TMF)4:35
The essential document system for every trial. TMF Reference Model. What goes in a TMF, the difference between Sponsor and Investigator TMFs, and TMF inspection readiness.
Getting a Trial Authorized — IND, CTA, and Clinical Hold8:45
The process of gaining and maintaining regulatory permission to study

Site Selection, Qualification, and Initiation6:48
Feasibility assessments, site qualification visits (SQV), site initiation visits (SIV). Regulatory submissions at site level. Investigator agreements and financial disclosure.
Patient Recruitment and Informed Consent4:52
Recruitment strategies, screen failure rates, enrolment challenges. The informed consent process in detail — ICF versions, re-consent, vulnerable populations, and GCP requirements.
Randomization, Blinding, and Unblinding7:04
Randomization types: simple, block, stratified, adaptive. Single blind, double blind, and open-label designs. Emergency unblinding procedures and documentation.
Monitoring — SDV, RBM, and Site Visits4:57
Traditional vs. Risk-Based Monitoring (RBM). On-site vs. centralised monitoring. Source data verification (SDV), source data review (SDR). Monitoring visit reports and CAPA.
Protocol Deviations and Trial Closeout7:03
Classification and reporting of protocol deviations. Major vs. minor deviations. Site closeout procedures, archival requirements, and regulatory notification of study completion.

CTMS — The Trial Management Backbone6:40
What a Clinical Trial Management System does: site tracking, enrolment dashboards, visit scheduling, issue logs, and financial management. Leading platforms: Veeva Vault CTMS, Medidata Rave, Oracle Siebel.
EDC — Electronic Data Capture2:45
How Electronic Data Capture replaced paper CRFs. eCRF design, data entry, queries, and audit trails. Validation and edit checks. Medidata Rave, Oracle InForm, and Veeva Vault EDC.
IWRS/IVRS — Randomization and Supply Management2:26
How Interactive Web/Voice Response Systems manage randomization, treatment assignment, and drug supply. Centralized vs. site-level randomization. Integration with the EDC.
eTMF, Medical Coding, and Central Labs3:07
Electronic Trial Master File systems. MedDRA and WHO Drug coding for adverse events and medications. Central laboratory systems, normal ranges, and lab data transfer to EDC.
The Integrated Ecosystem — Safety, ePRO, and Data Standards17:24
How all systems connect — and the standards that make it work

Case Report Forms — Design and Completion8:00
CRF design principles: data collected for each patient visit. Completion guidelines and source document requirements. Paper vs. electronic CRFs. The data management plan (DMP).
Data Cleaning, Queries, and Validation7:10
Programmatic edit checks and manual review. Raising, responding to, and closing data queries. Discrepancy management. The role of medical data review in cleaning.
Database Lock — The Critical Milestone7:57
The database lock process: pre-lock activities, quality tolerance limits, blind review, and the lock declaration. What changes are permissible after lock. Clean file vs. locked database.
Statistical Analysis Plans and Clinical Study Reports14:14
The Statistical Analysis Plan (SAP) and its relationship to the protocol. Analysis datasets (SDTM, ADaM). The Clinical Study Report (CSR) — ICH E3 structure — the primary submission document.

Adverse Events, SAEs, and Causality8:44
Definitions: AE, SAE, SUSAR, AESI. The seven SAE criteria. Causality assessment: related, possibly related, unrelated. Expected vs. unexpected events and the Investigator's Brochure.
SAE Reporting Timelines and Obligations7:31
Site-to-Sponsor reporting timelines (24h/48h). Sponsor-to-Regulator expedited SUSAR reporting: 7-day and 15-day rules. Annual Safety Reports (DSUR). Consequences of late reporting.
The DSMB — Independent Safety Oversight8:19
Role, composition, and independence of the Data Safety Monitoring Board. Interim analyses, stopping rules, and the DSMB charter. Open vs. closed sessions. When does a DSMB stop a trial?
Risk Management Plans and Signal Detection13:51
EU Risk Management Plans (RMP) and US REMS. Pharmacovigilance signal detection in databases. Benefit-risk assessment. Safety label changes and direct healthcare professional communications.

The Common Technical Document (CTD)9:22
The global standard for drug submissions. CTD structure: Module 1 (regional administrative), Module 2 (summaries), Module 3 (quality), Module 4 (non-clinical), Module 5 (clinical study reports).
NDA and BLA — US Marketing Applications6:37
New Drug Application vs. Biologics Licence Application. FDA review pathways: standard, priority, accelerated, breakthrough. PDUFA timelines, advisory committees, and Complete Response Letters.
MAA — European Marketing Authorization5:52
The EMA centralised procedure, mutual recognition, and decentralised procedure. CHMP assessment timeline. Conditional marketing authorisation and exceptional circumstances.
eCTD — Electronic Submissions and Publishing12:51
eCTD structure: backbone, sequences, and leaf files. Submission management tools. FDA ESG and EMA CESP portals. Regional specifics: Module 1 differences across US, EU, Japan, and Canada.

Requirements

No prior experience in clinical trials is required—just curiosity and a desire to grow your career. This course is designed for multiple backgrounds: For Career Switchers: If you're looking to break into the pharmaceutical or clinical research industry, this course will guide you from the ground up—no prior domain knowledge needed. For Students & Recent Graduates: Ideal for those studying life sciences, healthcare, or related fields who want to gain real-world knowledge and stand out in the job market. For Healthcare Professionals: Whether you're a nurse, pharmacist, physician, or allied health professional, this course will help you understand how clinical trials work and how you can transition into or collaborate with the clinical research space. All you need is a willingness to learn and an interest in how new medicines are developed, tested, and brought to market.

Description

This course contains the use of artificial intelligence to narrate the audios. Content of the course has been compiled and reviewed by Bashir Ahmed.

Unlock the world of clinical research and become part of the journey that brings life-saving treatments to patients.

Have you ever wondered how new medicines are developed, tested, and approved? Clinical trials are at the heart of every breakthrough in modern medicine—and this course is your complete, step-by-step guide to understanding how it all works.

Whether you're looking to break into the pharmaceutical industry, advance your healthcare career, or simply gain a solid foundation in clinical trials, this course is designed to take you from beginner to confident professional.

What You’ll Learn

The end-to-end clinical trial process—from discovery to regulatory approval
Key phases of clinical trials (Phase I, II, III, IV) explained simply
Roles and responsibilities across the clinical ecosystem (Sponsors, CROs, Investigators, Sites)
Core concepts like protocols, CRFs, eCRFs, and data management
Introduction to GCP (Good Clinical Practice) and regulatory compliance
How patient safety, ethics, and data integrity are ensured
Real-world workflows used in Clinical Operations, Data Management, and Regulatory teams
Career pathways and how to enter or grow in the clinical trials industry

Who This Course Is For

Career Switchers looking to enter the pharmaceutical or clinical research field
Students & Graduates in life sciences, healthcare, or related disciplines
Healthcare Professionals (nurses, pharmacists, physicians) wanting to expand into clinical research
Anyone curious about how medicines are tested and brought to market

Why This Course Stands Out

Beginner-friendly, yet comprehensive—no prior experience needed
Taught in a clear, structured, and practical way
Focus on real-world application, not just theory
Designed to give you the confidence to speak the language of clinical trials
Perfect foundation for roles in CROs, pharma companies, and research sites

Your Opportunity

The global clinical trials industry is growing rapidly, creating thousands of opportunities across the world. By understanding the fundamentals, you position yourself to enter a field that directly contributes to improving and saving lives.

If you’re ready to understand clinical trials from start to finish—and open the door to a new career path—enroll now and get started today.

Who this course is for:

Clinical operations professionals new to clinical trials
Pharmaceutical, biotech, and medical device company employees
• Regulatory affairs and quality assurance professionals
• Healthcare professionals considering a move into clinical research
• Data managers, biostatisticians, and clinical programmers
• Anyone seeking a structured, end-to-end understanding of how clinical trials work

Clinical Trials: A Complete Guide for Professionals

What you'll learn

Explore related topics

Course content

Introduction to Clinical Trials3 lectures • 15min

Phases of Clinical Trials4 lectures • 26min

The Clinical Trial Protocol3 lectures • 26min

Key Roles and Responsibilities5 lectures • 25min

The Regulatory Framework5 lectures • 30min

Trial Operations — Start-Up to Close-Out5 lectures • 31min

Clinical Trial Systems and Technology5 lectures • 32min

Clinical Data Management4 lectures • 37min

Safety Monitoring and Pharmacovigilance4 lectures • 38min

Regulatory Submissions4 lectures • 35min

Requirements

Description

Who this course is for: